Literature DB >> 27652202

From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel.

Chunxia Su1, Mathias Meyer2, Robert Pirker3, Wieland Voigt4, Jingyun Shi5, Lothar Pilz6, Rudolf M Huber7, Yilong Wu8, Jinghong Wang9, Yonglan He10, Xuan Wang10, Jian Zhang11, Xiuyi Zhi12, Meiqi Shi13, Bo Zhu14, Stefan S Schoenberg2, Thomas Henzler2, Christian Manegold15, Caicun Zhou1, Eric Dominic Roessner16.   

Abstract

The first Chinese-German Lung Cancer Expert Panel was held in November 2015 one day after the 7th Chinese-German Lung Cancer Forum, Shanghai. The intention of the meeting was to discuss strategies for the diagnosis and treatment of lung cancer within the context of lung cancer screening. Improved risk classification criteria and novel imaging approaches for screening populations are highly required as more than half of lung cancer cases are false positive during the initial screening round if the National Lung Screening Trial (NLST) demographic criteria [≥30 pack years (PY) of cigarettes, age ≥55 years] are applied. Moreover, if the NLST criteria are applied to the Chinese population a high number of lung cancer patients are not diagnosed due to non-smoking related risk factors in China. The primary goal in the evaluation of pulmonary nodules (PN) is to determine whether they are malignant or benign. Volumetric based screening concepts such as investigated in the Dutch-Belgian randomized lung cancer screening trial (NELSON) seem to achieve higher specificity. Chest CT is the best imaging technique to identify the origin and location of the nodule since 20% of suspected PN found on chest X-ray turn out to be non-pulmonary lesions. Moreover, novel state-of-the-art CT systems can reduce the radiation dose for lung cancer screening acquisitions down to a level of 0.1 mSv with improved image quality to novel reconstruction techniques and thus reduce concerns related to chest CT as the primary screening technology. The aim of the first part of this manuscript was to summarize the current status of novel diagnostic techniques used for lung cancer screening and minimally invasive treatment techniques for progressive PNs that were discussed during the first Chinese-German Lung Cancer. This part should serve as an educational part for the readership of the techniques that were discussed during the Expert Panel. The second part summarizes the consensus recommendations that were interdisciplinary discussed by the Expert Panel.

Entities:  

Keywords:  Lung cancer; modern imaging; molecular markers; pulmonary nodules (PN); response assessment; screening, minimally-invasive therapy

Year:  2016        PMID: 27652202      PMCID: PMC5009083          DOI: 10.21037/tlcr.2016.07.09

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  44 in total

1.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

2.  New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy.

Authors:  Ho Yun Lee; Kyung Soo Lee; Myung-Ju Ahn; Hye Sun Hwang; Ju Won Lee; Keunchil Park; Jin Seok Ahn; Tae Sung Kim; Chin A Yi; Myung Jin Chung
Journal:  Lung Cancer       Date:  2010-11-18       Impact factor: 5.705

3.  Unenhanced third-generation dual-source chest CT using a tin filter for spectral shaping at 100kVp.

Authors:  Holger Haubenreisser; Mathias Meyer; Sonja Sudarski; Thomas Allmendinger; Stefan O Schoenberg; Thomas Henzler
Journal:  Eur J Radiol       Date:  2015-04-28       Impact factor: 3.528

4.  Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Meta-analysis.

Authors:  N Bi; K Shedden; X Zheng; F Kong
Journal:  Pract Radiat Oncol       Date:  2013-03-25

Review 5.  Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST.

Authors:  Mizuki Nishino; Jyothi P Jagannathan; Katherine M Krajewski; Kevin O'Regan; Hiroto Hatabu; Geoffrey Shapiro; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2012-04       Impact factor: 3.959

6.  In vivo evaluation of lung microwave ablation in a porcine tumor mimic model.

Authors:  Olivier Planché; Christophe Teriitehau; Sana Boudabous; Joey Marie Robinson; Pramod Rao; Frederic Deschamps; Geoffroy Farouil; Thierry de Baere
Journal:  Cardiovasc Intervent Radiol       Date:  2012-05-03       Impact factor: 2.740

7.  Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.

Authors:  Thierry de Baère; Jean Palussière; Anne Aupérin; Antoine Hakime; Mohamed Abdel-Rehim; Michèle Kind; Clarisse Dromain; Alain Ravaud; Nathalie Tebboune; Valérie Boige; David Malka; Clarisse Lafont; Michel Ducreux
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

8.  Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Authors:  Rameses Sroufe; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 9.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

10.  When progressive disease does not mean treatment failure: reconsidering the criteria for progression.

Authors:  Geoffrey R Oxnard; Michael J Morris; F Stephen Hodi; Laurence H Baker; Mark G Kris; Alan P Venook; Lawrence H Schwartz
Journal:  J Natl Cancer Inst       Date:  2012-08-27       Impact factor: 13.506

View more
  4 in total

1.  How to diagnose pulmonary nodules: from screening to therapy.

Authors:  Yanwen Yao; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

2.  Efficacy of thoracoscopic anatomical segmentectomy for small pulmonary nodules.

Authors:  Hui Li; Yang Liu; Bao-Cun Ling; Bo Hu
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

3.  Implementation of sodium alginate-Fe3O4 to localize undiagnosed small pulmonary nodules for surgical management in a preclinical rabbit model.

Authors:  Zhi-Xuan Zhang; Lu Lv; Ai-Hua Shi; Yun-Hao Li; Tian-Ren Wang; Yuan-Hang Guo; Bao-Juan Hu; Xiao-Peng Yan; Jun-Ke Fu; Feng Ma; Hao-Hua Wang; Yi Lv; Yong Zhang
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

4.  Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Authors:  YangBo Hu; Huan Hu; LiYun Miao; Xin Zhao; Wei Gu; Wei Heng; ZiLi Meng; Jian Feng; Yi You; XingXiang Xu; Rong Hu; HaiQuan Li; Jie Zhao; XiaoLi Zhu; MeiQi Shi; Li Shen; XiuWei Zhang; XiaoWei Yin; Hang Ma; MinHua Shi; Yong Yu; Hong Lv; LiMing Cai; GaoHua Feng; YeQing Zhang; Feng Wu; TangFeng Lv; Yong Song
Journal:  Thorac Cancer       Date:  2018-01-17       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.